Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

"In the third quarter, we saw strong sales growth in Sweden, while partner discussions are taking time as we work to secure the right commercial terms for the product," says Claus Egstrand, CEO. " In the third quarter, we saw strong sales growth inSweden, while partner discussions are taking time as we work to secure the right commercial terms for the product," says Claus Egstrand, CEO. Significant events during the quarter Significant events after the quarter Other events...

LUND, Sweden, 30/10/2025 (informazione.news - comunicati stampa - scienza e tecnologia)

"

The full report is available at https://www.enzymatica.com/investors/financial-reports/

Claus Egstrand, CEO, Enzymatica AB
Phone: +44 7780 22 8385 | Email: claus.egstrand@enzymatica.com

Enzymatica AB is headquartered in Lund and is listed on Nasdaq First North Growth Market. For more information, visit www.enzymatica.se.

Enzymatica's Certified Adviser is DNB Carnegie Investment Bank AB (publ).

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/enzymatica-ab/r/quarterly-report-q3-2025--strong-development-in-sweden-and-continued-focus-on-international-expansio,c4258856

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/enzymatica-ab-quarterly-report-q32025-strong-development-in-sweden-and-continued-focus-on-international-expansion-302599565.html